LONG-ACTING PYY3−36 ANALOGUE WITH SEMAGLUTIDE FOR OBESITY: FROM PRECLINICAL ASSESSMENT THROUGH RANDOMIZED CLINICAL STUDIES

Descargar Publicación
Treating Sarcopenic Obesity in the Era of Incretin Therapies: Perspectives and Challenges Lipidomic profiling of human adiposomes identifies specific lipid shifts linked to obesity and cardiometabolic risk